Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 24/08/15

Trade details

Type
Insider sale
Amount
$550,766.79
Shares · price
1,701 sh · $323.79 a share
Held after
1,436 sh
Trade date
24/08/14
Filed
24/08/15
Days to filing
1 days

Sold 54.2% of holdings

Share of holding sold
54.2%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/15~24/09/13

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $220.2K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $218.9K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $153.5K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $131.9K

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $114.8K

    Filed 10/01

Martine A. Rothblatt, Chairman — sold $550.8K of United Therapeutics UTHR · 54.2% of holdings · 10b5-1 plan | Whalegun